2024 annual financial data
Cellyan Biotechnology 2024 Operating margin
Direct answer
Operating margin was 9.64%.
Operating income was 1,608,261 USD and net income was 1,329,717 USD.
Operating cash flow was -394,330 USD.
Get free Cellyan Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 16,688,364 USD
- Operating income
- 1,608,261 USD
- Net income
- 1,329,717 USD
- Operating cash flow
- -394,330 USD